| 1 | Baseline disease modifying therapies (DMTs) | - | - | - | - | 1件: 13 13 |
| 2 | BG00012 (DMF) | - | - | - | - | 1件: 13 13 |
| 3 | BG00012 (DMF) (Tecfidera®.) | - | - | - | - | 1件: 13 13 |
| 4 | Biologic DMARD | - | - | - | - | 2件: 46 46, 271 |
| 5 | Biological DMARDs | - | - | - | - | 2件: 86 86, 107 |
| 6 | Classic DMARDs treatment group | - | - | - | - | 1件: 46 46 |
| 7 | Co-medication: Synthetic DMARDs | - | - | - | - | 1件: 46 46 |
| 8 | Combination of DMARDs | - | - | - | - | 1件: 107 107 |
| 9 | Conventional DMARD combination | - | - | - | - | 1件: 46 46 |
| 10 | Conventional DMARDs | - | - | - | - | 1件: 46 46 |
| 11 | Conventional Synthetic DMARD | - | - | - | - | 1件: 46 46 |
| 12 | CP-690-550-10 (DMID D1600180) | - | - | - | - | 1件: 107 107 |
| 13 | Daunorubicin
(Synonym: DM) | 1件: Daunorubicin Daunorubicin | 2件: D01264
D01264
,
D07776
(Name: DM) | 2件: TOP2A TOP2A,
TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 65 65 |
| 14 | Dextromethorphan
(Synonym: Benylin DM (TN)) | 1件: Dextromethorphan Dextromethorphan (Synonym: ExeFen DMX) | 3件: D00848
D00848
(Name: Benylin DM (TN)),
D03742
,
D03744
| 6件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
| 15 | Dextromethorphan 30 mg
(Synonym: Benylin DM (TN)) | 1件: Dextromethorphan Dextromethorphan (Synonym: ExeFen DMX) | 3件: D00848
D00848
(Name: Benylin DM (TN)),
D03742
,
D03744
| 6件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 96 96, 97 |
| 16 | Dextromethorphan and Caffeine
(Synonym: Benylin DM (TN)) | 2件: Caffeine Caffeine,
Dextromethorphan (Synonym: ExeFen DMX) | 5件: D00528
D00528
,
D00848
(Name: Benylin DM (TN)),
D01453
,
D03742
,
D03744
| 17件: ADORA1 ADORA1,
ADORA2A,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A,
SIGMAR1 💬 | 37件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Huntington disease, Insulin signaling pathway, Long-term potentiation, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 78 78 |
| 17 | Dextromethorphan HBr and quinidine sulfate
(Synonym: Benylin DM (TN)) | 3件: Dextromethorphan Dextromethorphan (Synonym: ExeFen DMX),
Quinidine,
Sulfate ion | 7件: D00642
D00642
,
D00643
,
D00848
(Name: Benylin DM (TN)),
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 2 2 |
| 18 | DEXTROMETHORPHAN HYDROBROMIDE
(Synonym: Benylin DM (TN)) | 1件: Dextromethorphan Dextromethorphan (Synonym: ExeFen DMX) | 3件: D00848
D00848
(Name: Benylin DM (TN)),
D03742
,
D03744
| 6件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 13 13, 46 |
| 19 | Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg
(Synonym: Benylin DM (TN)) | 3件: Dextromethorphan Dextromethorphan (Synonym: ExeFen DMX),
Quinidine,
Sulfate ion | 7件: D00642
D00642
,
D00643
,
D00848
(Name: Benylin DM (TN)),
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 2件: 2 2, 13 |
| 20 | Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg
(Synonym: Benylin DM (TN)) | 3件: Dextromethorphan Dextromethorphan (Synonym: ExeFen DMX),
Quinidine,
Sulfate ion | 7件: D00642
D00642
,
D00643
,
D00848
(Name: Benylin DM (TN)),
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 2件: 2 2, 13 |
| 21 | Dextromethorphan/Quinidine
(Synonym: Benylin DM (TN)) | 2件: Dextromethorphan Dextromethorphan (Synonym: ExeFen DMX),
Quinidine | 7件: D00642
D00642
,
D00643
,
D00848
(Name: Benylin DM (TN)),
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
| 22 | Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg) | 2件: Dextromethorphan Dextromethorphan (Synonym: ExeFen DMX),
Quinidine | 7件: D00642
D00642
,
D00643
,
D00848
(Name: Benylin DM (TN)),
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 8 8 |
| 23 | Diagnostic Test: DM1-ActivC | - | - | - | - | 1件: 113 113 |
| 24 | Dimebon + Dextromethorphan
(Synonym: Benylin DM (TN)) | 2件: Dextromethorphan Dextromethorphan (Synonym: ExeFen DMX),
Latrepirdine | 4件: D00848
D00848
(Name: Benylin DM (TN)),
D03742
,
D03744
,
D09917
| 7件: ACHE ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
| 25 | Dimethyl Fumarate (DMF) | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 3件: 13 13, 51, 86 |
| 26 | Dimethyl fumarate [DMF] | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 |
| 27 | Dimethyl sulfoxide (DMSO) | 1件: Dimethyl sulfoxide Dimethyl sulfoxide (Synonym: DMSO) | 1件: D01043
D01043
| - | - | 1件: 226 226 |
| 28 | Disease modifying treatment (DMT) | - | - | - | - | 1件: 13 13 |
| 29 | Disease-modifying antirheumatic drugs (DMARDs) | - | - | - | - | 1件: 46 46 |
| 30 | DM | - | - | - | - | 2件: 6 6, 8 |
| 31 | DM-1992 | - | - | - | - | 1件: 6 6 |
| 32 | DMARD | - | - | - | - | 1件: 46 46 |
| 33 | DMARD cessation | - | - | - | - | 1件: 46 46 |
| 34 | DMARD maintenance | - | - | - | - | 1件: 46 46 |
| 35 | DMARD Therapy | - | - | - | - | 1件: 46 46 |
| 36 | DMARDS | - | - | - | - | 2件: 46 46, 271 |
| 37 | DMARDs (disease-modifying antirheumatic drugs) | - | - | - | - | 1件: 46 46 |
| 38 | DMARDs (methotrexate | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR,
DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
| 39 | DMARDs or Biologics | - | - | - | - | 1件: 46 46 |
| 40 | DMPS | 1件: 2,3-Dimercapto-1-propanesulfonic acid 2,3-Dimercapto-1-propanesulfonic acid (Synonym: DMPS) | - | - | - | 1件: 171 171 |
| 41 | DMSA | 1件: Succimer Succimer (Synonym: DMSA) | 1件: D00572
D00572
| - | - | 1件: 171 171 |
| 42 | DMSO | 1件: Dimethyl sulfoxide Dimethyl sulfoxide (Synonym: DMSO) | 1件: D01043
D01043
| - | - | 1件: 226 226 |
| 43 | DMSO cocktail | 1件: Dimethyl sulfoxide Dimethyl sulfoxide (Synonym: DMSO) | 1件: D01043
D01043
| - | - | 1件: 226 226 |
| 44 | DMT | - | - | - | - | 1件: 13 13 |
| 45 | DMT continuation | - | - | - | - | 1件: 13 13 |
| 46 | DMX-200 | - | - | - | - | 1件: 222 222 |
| 47 | Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc | 1件: Etanercept Etanercept | 1件: D00742
D00742
| 2件: LTA LTA,
TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
| 48 | Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS | - | - | - | - | 1件: 13 13 |
| 49 | First line DMT | - | - | - | - | 1件: 13 13 |
| 50 | HUC-MSC + DMARDs | - | - | - | - | 1件: 46 46 |
| 51 | Injectable MS DMT | - | - | - | - | 1件: 13 13 |
| 52 | IONIS-DMPKRx | - | - | - | - | 1件: 113 113 |
| 53 | Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD) | - | - | - | - | 1件: 46 46 |
| 54 | Non-Biologic DMARDs | - | - | - | - | 3件: 46 46, 86, 107 |
| 55 | Non-biological DMARD's | - | - | - | - | 1件: 46 46 |
| 56 | Non-biological DMARDs | - | - | - | - | 1件: 46 46 |
| 57 | Nonbiologic DMARDs of investigator's choice | - | - | - | - | 1件: 46 46 |
| 58 | Other DMARDs | - | - | - | - | 1件: 46 46 |
| 59 | Other: DMT withdrawal | - | - | - | - | 1件: 13 13 |
| 60 | Other: Group 2 (DMARDS treated group) | - | - | - | - | 1件: 46 46 |
| 61 | Other: Other: Disease modifying therapies (DMT) | - | - | - | - | 1件: 13 13 |
| 62 | Patient treated with DMARD | - | - | - | - | 1件: 46 46 |
| 63 | Permitted DMARDs | - | - | - | - | 1件: 46 46 |
| 64 | Phase 1: Conventiaonal DMARD | - | - | - | - | 1件: 46 46 |
| 65 | Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs) | - | - | - | - | 1件: 46 46 |
| 66 | Standard DMARDs (Disease Modifying Anti Rheumatic Drugs) | - | - | - | - | 1件: 46 46 |
| 67 | Standard MS DMT | - | - | - | - | 1件: 13 13 |
| 68 | Standard MS DMTs | - | - | - | - | 1件: 13 13 |
| 69 | Synthetic DMARD(s) | - | - | - | - | 1件: 46 46 |
| 70 | Therapy with disease-modifying anti rheumatic drugs (DMARD) | - | - | - | - | 1件: 46 46 |
| 71 | TNF-a antagonists, non-TNFs, DMARD non-biologics | - | - | - | - | 2件: 46 46, 271 |
| 72 | UC-MSC+DMARDS | - | - | - | - | 1件: 46 46 |
| 73 | Vinblastine, vincristine, prednisone, daunorubicin
(Synonym: DM) | 4件: Daunorubicin Daunorubicin,
Prednisone,
Vinblastine,
Vincristine | 7件: D00473
D00473
,
D01068
,
D01264
,
D02197
,
D07776
(Name: DM),
D08675
,
D08679
| 12件: NR3C1 NR3C1,
TOP2A,
TOP2B,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 | 12件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Platinum drug resistance, Prion disease, Salmonella infection 💬 | 1件: 65 65 |